Hope in Hard Places: A Potential New Option for Patients with Pancreatic Cancer Podcast Por arte de portada

Hope in Hard Places: A Potential New Option for Patients with Pancreatic Cancer

Hope in Hard Places: A Potential New Option for Patients with Pancreatic Cancer

Escúchala gratis

Ver detalles del espectáculo
Metastatic pancreatic cancer remains one of the deadliest cancers, but a new approach is taking shape - and it's showing promise in early clinical studies. In this episode, Dan Schmitt, President and CEO of Actuate Therapeutics, shares how elraglusib, an investigational targeted therapy, may provide a new option for patients with metastatic pancreatic cancer. We explore the urgent unmet need and why Dan thinks this could be a turning point for one of oncology's toughest challenges.
Todavía no hay opiniones